Clinical Trial Update: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 drug-drug interaction study evaluating AZD5335 with itraconazole in ovarian-, fallopian tube-, or primary peritoneal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• AZD5335 (AZD5335)
• Itraconazole (Itraconazole)

Snippet

Sponsor: AstraZeneca | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: RECRUITING